Agios Pharmaceuticals AGIO Operating Lease Weighted Average Discount Rate Percent
Operating Lease Weighted Average Discount Rate Percent at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's operating lease weighted average discount rate percent?
- Agios Pharmaceuticals (AGIO) reported operating lease weighted average discount rate percent of $0.06 in Q1 2026.
- How has Agios Pharmaceuticals's operating lease weighted average discount rate percent changed year-over-year?
- Agios Pharmaceuticals's operating lease weighted average discount rate percent decreased by 0.0% year-over-year, from $0.06 to $0.06.
- What is the long-term trend for Agios Pharmaceuticals's operating lease weighted average discount rate percent?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's operating lease weighted average discount rate percent has grown at a 0.0% compound annual growth rate (CAGR), from $0.06 to $0.06.